105 related articles for article (PubMed ID: 11485409)
1. HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells.
Selliah N; Finkel TH
Virology; 2001 Aug; 286(2):412-21. PubMed ID: 11485409
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness.
Selliah N; Finkel TH
J Immunol; 1998 Jun; 160(12):5697-701. PubMed ID: 9637477
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
[TBL] [Abstract][Full Text] [Related]
4. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
5. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
6. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.
Yamashita M; Katsumata M; Iwashima M; Kimura M; Shimizu C; Kamata T; Shin T; Seki N; Suzuki S; Taniguchi M; Nakayama T
J Exp Med; 2000 Jun; 191(11):1869-79. PubMed ID: 10839803
[TBL] [Abstract][Full Text] [Related]
8. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
9. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
[TBL] [Abstract][Full Text] [Related]
10. Ligation of RARgamma inhibits proliferation of phytohaemagglutinin-stimulated T-cells via down-regulating JAK3 protein levels.
Ludányi K; Nagy ZS; Alexa M; Reichert U; Michel S; Fésüs L; Szondy Z
Immunol Lett; 2005 Apr; 98(1):103-13. PubMed ID: 15790515
[TBL] [Abstract][Full Text] [Related]
11. Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.
Wasik MA; Nowak I; Zhang Q; Shaw LM
Leuk Lymphoma; 1998 Feb; 28(5-6):551-60. PubMed ID: 9613985
[TBL] [Abstract][Full Text] [Related]
12. Down-modulation of IL-2-triggered JAK3-STAT5 signaling following CD4-ligand binding.
Lowry RP; Goebel J
Transplant Proc; 1999; 31(1-2):820-1. PubMed ID: 10083356
[No Abstract] [Full Text] [Related]
13. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
Grundström S; Dohlsten M; Sundstedt A
J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
[TBL] [Abstract][Full Text] [Related]
14. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion.
Lee IH; Li WP; Hisert KB; Ivashkiv LB
J Exp Med; 1999 Nov; 190(9):1263-74. PubMed ID: 10544198
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes.
Kryworuchko M; Pasquier V; Thèze J
Clin Exp Immunol; 2003 Mar; 131(3):422-7. PubMed ID: 12605694
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway.
Bingisser RM; Tilbrook PA; Holt PG; Kees UR
J Immunol; 1998 Jun; 160(12):5729-34. PubMed ID: 9637481
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
Kanner SB; Haffar OK
J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
[TBL] [Abstract][Full Text] [Related]
19. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor.
Miyatake S; Sakuma M; Saito T
Eur J Immunol; 1997 Jul; 27(7):1816-23. PubMed ID: 9247597
[TBL] [Abstract][Full Text] [Related]
20. Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy.
Kryworuchko M; Pasquier V; Keller H; David D; Goujard C; Gilquin J; Viard JP; Joussemet M; Delfraissy JF; Thèze J
AIDS; 2004 Feb; 18(3):421-6. PubMed ID: 15090793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]